🚀 VC round data is live in beta, check it out!

Pets at Home Valuation Multiples

Discover revenue and EBITDA valuation multiples for Pets at Home and similar public comparables like Medplus Health Services, Arhaus, MAP Active, Pet Valu and more.

Pets at Home Overview

About Pets at Home

Pets at Home Group PLC is an omnichannel British retailer operating mainly in the United Kingdom. The company has a network of stores, websites, grooming salons, and pet services, such as veterinary. The product portfolio is diverse, including items for dogs, cats, fish, reptiles, birds, and wildlife. The items sold are from the following categories: food, pet beds, toys, pet clothing, kennels, collars, healthcare, grooming, training, books, and accessories. The products are sold under the Pets at Home brand, private brand, and labels. The veterinary services are located within stores, as well as in stand-alone locations, throughout the U.K.


Founded

2014

HQ

United Kingdom

Employees

11.6K

Financials (LTM)

Revenue: $2B
EBITDA: $279M

EV

$2B

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Pets at Home Financials

Pets at Home reported last 12-month revenue of $2B and EBITDA of $279M.

In the same LTM period, Pets at Home generated $963M in gross profit, $279M in EBITDA, and $92M in net income.

Revenue (LTM)


Pets at Home P&L

In the most recent fiscal year, Pets at Home reported revenue of $2B and EBITDA of $336M.

Pets at Home expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Pets at Home forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue$2BXXX$2BXXXXXXXXX
Gross Profit$963MXXX$940MXXXXXXXXX
Gross Margin48%XXX47%XXXXXXXXX
EBITDA$279MXXX$336MXXXXXXXXX
EBITDA Margin14%XXX17%XXXXXXXXX
EBIT Margin7%XXX10%XXXXXXXXX
Net Profit$92MXXX$131MXXXXXXXXX
Net Margin5%XXX7%XXXXXXXXX

Financial data powered by Morningstar, Inc.

Pets at Home Stock Performance

Pets at Home has current market cap of $1B, and enterprise value of $2B.

Market Cap Evolution


Pets at Home's stock price is $2.58.

See Pets at Home trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2B$1B0.0%XXXXXXXXX$0.30

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Pets at Home Valuation Multiples

Pets at Home trades at 0.8x EV/Revenue multiple, and 5.8x EV/EBITDA.

See valuation multiples for Pets at Home and 15K+ public comps

EV / Revenue (LTM)


Pets at Home Financial Valuation Multiples

As of April 19, 2026, Pets at Home has market cap of $1B and EV of $2B.

Equity research analysts estimate Pets at Home's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Pets at Home has a P/E ratio of 12.5x.

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$1BXXX$1BXXXXXXXXX
EV (current)$2BXXX$2BXXXXXXXXX
EV/Revenue0.8xXXX0.8xXXXXXXXXX
EV/EBITDA5.8xXXX4.8xXXXXXXXXX
EV/EBIT11.0xXXX8.1xXXXXXXXXX
EV/Gross Profit1.7xXXX1.7xXXXXXXXXX
P/E12.5xXXX8.7xXXXXXXXXX
EV/FCF22.6xXXX7.1xXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Pets at Home Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Pets at Home Margins & Growth Rates

Pets at Home's revenue in the last 12 month grew by 2%.

Pets at Home's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Pets at Home's rule of 40 is 15% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Pets at Home's rule of X is 17% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Pets at Home and other 15K+ public comps

Pets at Home Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue Growth2%XXX(0%)XXXXXXXXX
EBITDA Margin14%XXX17%XXXXXXXXX
EBITDA Growth4%XXX(17%)XXXXXXXXX
Rule of 40—XXX15%XXXXXXXXX
Bessemer Rule of X—XXX17%XXXXXXXXX
Revenue per Employee—XXX$0.2MXXXXXXXXX
Opex per Employee—XXX$0.1MXXXXXXXXX
S&M Expenses to Revenue—XXX30%XXXXXXXXX
G&A Expenses to Revenue11%XXX9%XXXXXXXXX
Opex to Revenue—XXX38%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Pets at Home Public Comps

See public comps and valuation multiples for other Specialty Stores comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
Pets at HomeXXXXXXXXXXXXXXXXXX
Medplus Health ServicesXXXXXXXXXXXXXXXXXX
ArhausXXXXXXXXXXXXXXXXXX
MAP ActiveXXXXXXXXXXXXXXXXXX
Pet ValuXXXXXXXXXXXXXXXXXX
Siam Global HouseXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Pets at Home M&A Activity

Pets at Home acquired XXX companies to date.

Last acquisition by Pets at Home was on XXXXXXXX, XXXXX. Pets at Home acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Pets at Home

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Pets at Home Investment Activity

Pets at Home invested in XXX companies to date.

Pets at Home made its latest investment on XXXXXXXX, XXXXX. Pets at Home invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Pets at Home

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Pets at Home

When was Pets at Home founded?Pets at Home was founded in 2014.
Where is Pets at Home headquartered?Pets at Home is headquartered in United Kingdom.
How many employees does Pets at Home have?As of today, Pets at Home has over 11K employees.
Is Pets at Home publicly listed?Yes, Pets at Home is a public company listed on London Stock Exchange.
What is the stock symbol of Pets at Home?Pets at Home trades under PETS ticker.
When did Pets at Home go public?Pets at Home went public in 2014.
Who are competitors of Pets at Home?Pets at Home main competitors are Medplus Health Services, Arhaus, MAP Active, Pet Valu.
What is the current market cap of Pets at Home?Pets at Home's current market cap is $1B.
What is the current revenue of Pets at Home?Pets at Home's last 12 months revenue is $2B.
What is the current revenue growth of Pets at Home?Pets at Home revenue growth (NTM/LTM) is 2%.
What is the current EV/Revenue multiple of Pets at Home?Current revenue multiple of Pets at Home is 0.8x.
Is Pets at Home profitable?Yes, Pets at Home is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Pets at Home?Pets at Home's last 12 months EBITDA is $279M.
What is Pets at Home's EBITDA margin?Pets at Home's last 12 months EBITDA margin is 14%.
What is the current EV/EBITDA multiple of Pets at Home?Current EBITDA multiple of Pets at Home is 5.8x.
What is the current FCF of Pets at Home?Pets at Home's last 12 months FCF is $71M.
What is Pets at Home's FCF margin?Pets at Home's last 12 months FCF margin is 4%.
What is the current EV/FCF multiple of Pets at Home?Current FCF multiple of Pets at Home is 22.6x.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial